Comprehensive mutational profiling in advanced systemic mastocytosis
Open Access
- 3 October 2013
- journal article
- Published by American Society of Hematology in Blood
- Vol. 122 (14), 2460-2466
- https://doi.org/10.1182/blood-2013-04-496448
Abstract
Key Points Additional genetic aberrations apart from KIT D816V are found in advanced systemic mastocytosis. Additional genetic aberrations apart from KIT D816V are associated with a significant reduction of overall survival.Keywords
This publication has 39 references indexed in Scilit:
- Systemic mastocytosis in adults: 2012 Update on diagnosis, risk stratification, and managementAmerican Journal of Hematology, 2012
- Improved Detection of the KIT D816V Mutation in Patients with Systemic Mastocytosis Using a Quantitative and Highly Sensitive Real-Time qPCR AssayThe Journal of Molecular Diagnostics, 2011
- WHO subvariants of indolent mastocytosis: clinical details and prognostic evaluation in 159 consecutive adultsBlood, 2010
- Variable presence of KITD816V in clonal haematological non‐mast cell lineage diseases associated with systemic mastocytosis (SM–AHNMD)The Journal of Pathology, 2009
- Recent advances in the understanding of mastocytosis: the role of KIT mutations*British Journal of Haematology, 2007
- Standards and standardization in mastocytosis: Consensus Statements on Diagnostics, Treatment Recommendations and Response CriteriaEuropean Journal of Clinical Investigation, 2007
- PKC412 inhibits in vitro growth of neoplastic human mast cells expressing the D816V-mutated variant of KIT: comparison with AMN107, imatinib, and cladribine (2CdA) and evaluation of cooperative drug effectsBlood, 2006
- Dasatinib (BMS-354825), a Dual SRC/ABL Kinase Inhibitor, Inhibits the Kinase Activity of Wild-Type, Juxtamembrane, and Activation Loop Mutant KIT Isoforms Associated with Human MalignanciesCancer Research, 2006
- The systemic mastocytosis-specific activating cKit mutation D816V can be inhibited by the tyrosine kinase inhibitor AMN107Leukemia, 2005
- Diagnostic criteria and classification of mastocytosis: a consensus proposalLeukemia Research, 2001